INFOSYS Q2 MGMT COMMENTARY

CEO says We had strong large deals of $5.2 billion, including a mega deal of over $2 billion, reinforcing our position as a trusted partner in the marketplace when clients embark on large and complex transformation programs.

Our Al revenue was at 10.5% and grew 29% quarter-on-quarter.

As enterprises move to Al adoption at scale, the strong growth in Al revenues is a recognition of our differentiated market positioning and client confidence

CEO says We are advising some of the largest global enterprise on their Al strategy and continue to invest in deep domain and technology capabilities to bring new ideas and an integrated ecosystem to help businesses unlock Al value at scale

Coforge Ltd – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Financial results for the quarter ended September 30, 2026:

- Revenue: $652.2 Mn (+40.1% YoY)

- EBIT Margin: 16.0% (FY27 guidance upgraded from 15.5% to 16.0%)

- EBIT: $104.1 Mn (+53.0% YoY)

- PAT: $62.2 Mn (+42.7% YoY)

- EPS: ₹13.3 (+18.3% YoY)

- Fresh Order Intake: $1.04 Bn (+50.6% QoQ)

📊 INFOSYS Q2 FY27

• CC Revenue Growth: 1.2% QoQ vs 1.4% estimate

• USD Revenue: $5,145 Mn, up 1% QoQ vs $5,151 Mn estimate

• Total Contract Value (TCV): $5.2 Bn, up 44% QoQ

TORRENT PHARMACEUTICALS Q2FY27 :-

Revenue 4,979.00 Cr vs 3,302.00 Cr
(+50.79% YoY┃+1.18% QoQ)

EBITDA 1,666.00 Cr vs 1,083.00 Cr
(+53.83% YoY┃+0.12% QoQ)

EBITDA Margin 33.46% vs 32.80% YoY & 33.82% QoQ

PAT 534.00 Cr vs 591.00 Cr
(-9.64% YoY┃-5.65% QoQ)

EPS 14.05 vs 17.45 YoY & 14.87 QoQ

CUBEX TUBINGS Q2 FY27 (STANDALONE)

Net Profit: ₹5 Cr ↑163% YoY | ↑236% QoQ

Revenue: ₹83 Cr ↑13% YoY | ↑28% QoQ

EBITDA: ₹7 Cr ↑119% YoY | ↑407% QoQ

EBITDA Margin: 8.6% vs 4.4% YoY | 2.2% QoQ

TORRENT PHARMA Q2 FY27

Net Profit: ₹534 Cr ↓10% YoY | ↓6% QoQ

Revenue: ₹4,979 Cr ↑51% YoY | ↑1% QoQ

Operating Profit: ₹1,666 Cr ↑54% YoY | Flat QoQ

Operating Profit Margin: 33.5% vs 32.8% YoY | 33.8% QoQ

EPS: ₹14.05 ↓19% YoY | ↓6% QoQ

📊 INFOSYS Q2 FY27 – ACTUAL vs ESTIMATES

• Net Profit: ₹7,823 Cr vs ₹7,917 Cr — Miss by 1.19% 🔴

• Revenue: ₹49,244 Cr vs ₹49,194 Cr — Beat by 0.10% 🟢

• EBIT: ₹10,330 Cr vs ₹10,470 Cr — Miss by 1.34% 🔴

• EBIT Margin: 21.0% vs 21.3% estimated — Miss by 30 bps 🔴

Tata Motors Ltd – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Investor presentation for the quarter and half-year ended September 30, 2026:

- Standalone Revenue: INR 23900 Cr (up 42% YoY)

- Standalone EBITDA: INR 2800 Cr (up 31% YoY)

- Consolidated Revenue: INR 25300 Cr (up 36% YoY)

- Consolidated PBT (bei): INR 1800 Cr (up 423% YoY)

- Q2 Standalone Wholesales: 135.1K units (up 42% YoY)

- International Business Wholesales: 21.1K units (up 177% YoY)

Bank of India – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Unaudited (Reviewed) Standalone & Consolidated results for the quarter ended 30.09.2026:

- Net Profit: INR 3202 Cr (up 25% YoY)

- Global Business Mix: INR 1892601 Cr (up 21.13% YoY)

- Global Deposits: INR 1037530 Cr (up 21.59% YoY)

- Global Advances: INR 855071 Cr (up 20.58% YoY)

- Gross NPA: 1.60% (down from 2.54% YoY)

- Net NPA: 0.42% (down from 0.65% YoY)

BANK OF INDIA Q2 FY27 (STANDALONE)

Net Profit: ₹3,202 Cr ↑25.32% YoY | ↑4.37% QoQ

NII: ₹7,007 Cr ↑18.48% YoY | ↑2.55% QoQ

PPOP: ₹5,089 Cr ↑1% QoQ

Provisions: ₹797 Cr ↓17% QoQ

Gross NPA: 1.60% vs 1.81% QoQ

Net NPA: 0.42% vs 0.51% QoQ

JK TYRE & INDUSTRIES Q2 FY27 (CONS.)

Net Profit: ₹65.07 Cr ↓71.32% YoY | ↑47.58% QoQ

Revenue: ₹4,840.73 Cr ↑20.68% YoY | ↑22.67% QoQ

EBITDA: ₹333.91 Cr ↓35.96% YoY | ↑29.31% QoQ

EBITDA Margin: 6.90% vs 13.00% YoY | 6.54% QoQ

CRISIL Q2 FY26 (CONS.)

Net Profit: ₹204.54 Cr ↑5.92% YoY | ↓5.46% QoQ

Revenue: ₹1,095.16 Cr ↑20.18% YoY | ↑1.84% QoQ

EBITDA: ₹327.90 Cr ↑3.25% YoY | ↓1.32% QoQ

EBITDA Margin: 29.94% vs 34.85% YoY | 30.90% QoQ

SBI Funds Management Ltd – Q2 FY27 FINANCIAL RESULTS HIGHLIGHTS

Investor presentation for the quarter and half year ended September 30, 2026:

- MF QAAUM: INR 13,140 bn (15.0% market share)

- Passive QAAUM: INR 4,152 bn (27.4% market share)

- AIF QAAUM: INR 7437 Cr (up 27% YoY)

- SIP AUM: INR 2,070 bn (up 15% YoY)

- H1 FY27 Operating Income: INR 2336 Cr (up 12% YoY)

- H1 FY27 Operating Profit: INR 1797 Cr (up 11% YoY)

DR REDDY'S LABS Q2 FY27 (CONS.)

Net Profit: ₹913 Cr ↓31.71% YoY | ↑109.40% QoQ

Revenue: ₹8,698 Cr ↓1.47% YoY | ↑7.38% QoQ

EBITDA: ₹1,731 Cr ↓13.88% YoY | ↑101.28% QoQ

EBITDA Margin: 19.90% vs 22.77% YoY | 10.62% QoQ

Dr Reddys Laboratories Ltd – Q2FY27 FINANCIAL RESULTS UPDATE

Financial highlights for the quarter ended September 2026:

- Reported Revenues: INR 8671 Cr (up 1.5% YoY, 7% QoQ)

- EBITDA: INR 1783 Cr (up 24% YoY, 77% QoQ) at 20.6% margin

- PBT: INR 1228 Cr (up 33% YoY, 122% QoQ)

- PAT: INR 925 Cr (up 36% YoY, 109% QoQ)

- Net Cash surplus: INR 2502 Cr

- CDMO business (Aurigene): Surpassed $100 million in revenues for 12 months ended Sep'26

Dr Reddys Laboratories Ltd – APPOINTMENT OF SENIOR MANAGEMENT PERSONNEL

Appointment of new Head API and Services effective November 13, 2026:

- Mr. Akhil Ravi appointed as Head API and Services and Senior Management Personnel

- Mr. Akhil Ravi inducted as a Member of the Management Council

- He will continue to lead operations of Aurigene Pharmaceutical Services Ltd (wholly owned subsidiary)

- Mr. Akhil Ravi brings nearly 19 years of experience in strategy and commercial leadership

- He currently serves as CEO of Aurigene Pharmaceutical Services Ltd

GEOJIT FINANCIAL SERVICES Q2 FY27 (CONS.)

Net Profit: ₹16.28 Cr ↓30.62% YoY | ↓17.87% QoQ

Revenue: ₹165.82 Cr ↑2.56% YoY | ↑3.38% QoQ

EBITDA: ₹30.34 Cr ↓1.57% YoY | ↓4.41% QoQ

EBITDA Margin: 18.30% vs 19.06% YoY | 19.79% QoQ

RAMCO SYSTEMS Q2 FY27

Net Profit: ₹0.5 Cr ↓96% YoY | ↓20% QoQ

Revenue: ₹182 Cr ↑4% YoY | ↑5% QoQ

EBITDA: ₹26 Cr ↓34% YoY | ↑1% QoQ

EBITDA Margin: 14.2% vs 22.4% YoY | 14.7% QoQ

SHAKTI PUMPS Q2 FY27

Net Profit: ₹39 Cr ↓58% YoY | ↓25% QoQ

Revenue: ₹746 Cr ↑12% YoY | ↓13% QoQ

EBITDA: ₹64 Cr ↓53% YoY | ↓23% QoQ

EBITDA Margin: 8.6% vs 20.4% YoY | 9.6% QoQ

RUNWAL ENTERPRISES Q1 FY27 (CONS.)

Net Profit: ₹49.76 Cr ↓65.21% YoY | ₹62.02 Cr loss QoQ

Revenue: ₹338.16 Cr ↓24.21% YoY | ↑60.29% QoQ

EBITDA: ₹66.43 Cr ↓57.82% YoY | ₹39.74 Cr loss QoQ

EBITDA Margin: 19.65% vs 35.30% YoY | -18.84% QoQ

SHIVA CEMENT Q2 FY27

Net Loss: ₹22.85 Cr vs ₹32.73 Cr loss YoY | ₹21.35 Cr loss QoQ

Revenue: ₹112.70 Cr ↑37.25% YoY | ↓25.61% QoQ

EBITDA: ₹17.31 Cr ↑331.45% YoY | ↓7.19% QoQ

EBITDA Margin: 15.36% vs 4.89% YoY | 12.31% QoQ